Abstract: An exercise apparatus comprising: a frame having a first vertical guide and a second vertical guide; a first selectorized weight stack and a second selectorized weight stack coupled to the frame; a first carriage assembly and a second carriage assembly coupled to the first and second selectorized weight stacks, respectively, each of the first and second carriage assemblies comprising a rack having a number of openings; and an exercise bar movably coupled to the frame, the exercise bar having a first end comprising a first latching hook and a second end having a second latching hook, the first latching hook or the second latching hook configured to engage or disengage with an opening of the number of openings in the rack to adjust a resistance of the exercise bar.

Abstract: A screen stand to retrofit onto a stationary exercise machine using existing bolts on the stationary exercise machine. The screen stand has a hollow top mast slidably received within a hollow bottom mast. The bottom mast has a first anchor to attach to the pop pin of the stationary bicycle. There is a second anchor that attaches to the front stabilizer bar of the stationary bicycle.

Abstract: A screen stand to retrofit onto a stationary exercise machine using existing bolts on the stationary exercise machine. The screen stand has a hollow top mast slidably received within a hollow bottom mast. The bottom mast has a first anchor to attach to the pop pin of the stationary bicycle. There is a second anchor that attaches to the front stabilizer bar of the stationary bicycle.

Abstract: A synthetic calcium phosphate-based biomedical material comprising gadolinium. The material may comprises a compound having the general chemical formula: Ca10?yGdy(PO4)6?x(SiO4)x(OH)2?x+y where 0<x<1.3 and 0<y<1.3.

Abstract: A synthetic calcium phosphate-based biomedical material comprising gadolinium. The material may comprises a compound having the general chemical formula: Ca10?yGdy(PO4)6?x(SiO4)x(OH)2?x+y where 0<x<1.3 and 0<y<1.3.

Abstract: A synthetic calcium phosphate-based biomedical material comprising gadolinium. The material may comprises a compound having the general chemical formula: Ca10?yGdy(PO4)6?x(SiO4)x(OH)2?c+y where 0<x<1.3 and 0<y<1.3.

Abstract: Methods, systems, and devices for wireless communication are described including determining one or more unfiltered CFOs, filtering the one or more unfiltered CFOs to identify a refined CFO based at least in part on the one or more unfiltered CFOs and a predetermined number of packets, modifying a transmission parameter based at least in part on the refined CFO, and transmitting a signal in a MU-MIMO environment based at least in part on the modified transmission parameter.

Abstract: A synthetic calcium phosphate-based biomedical material comprising gadolinium. The material may comprises a compound having the general chemical formula: Ca10?yGdy(PO4)6?x(SiO4)x(OH)2?c+y where 0<x<1.3 and 0<y<1.3.

Abstract: A synthetic calcium phosphate-based biomedical material comprising gadolinium. The material may comprise a compound having the general chemical formula: Ca10?yGdy(PO4)6?x(SiO4)x(OH)2?x+y where 0<x<1.3 and 0<y<1:3.

Abstract: The bone graft system comprises a solid inorganic component, which is bone graft material, and a hydrogel. The hydrogel contains >2 ppm of silicon ions, calculated as parts by weight of Si per million of the aqueous component of the hydrogel. Preferably, the solid inorganic component comprises hydroxyapatite or a silicon-containing hydroxyapatite, and may be a silicon-containing hydroxyapatite having a Ca/P ratio in the range 2.05 to 2.55 and a Ca/(P+Si) molar ratio less than 1.66. Bone healing is promoted by delivery of silicon ion release from the hydrogel and by the solid inorganic component stimulating cell behavior.

Abstract: The invention relates to porous granular calcium phosphate osteoinductive materials, particularly materials useful in body tissue repair, principally bone repair and bone replacement, and also to the use of such materials and to a method of making such materials. Exemplary materials comprise discrete porous granules each containing crystals of at least one calcium phosphate, wherein (i) at least 90% of said crystals of the granules have a crystal size in the range 10-100 nm, (ii) at least 90% of the pores in the granules have a pore size in the range 10-500 nm, (iii) the average pore size of the pores having pore size in the range 10-500 nm in the granules is in the range 30-90 nm, (iv) the total volume porosity of the granules is at least 50%, and (v) the surface area of the granules is in the range 10-70 m2/g.

Abstract: A process for the synthesis of a bioceramic composition comprising calcium phosphosilicate (CPS, Ca10(PO4)4(SiO4)2), the process comprising: providing calcium or a calcium-containing compound, a phosphorus-containing compound and a silicon-containing compound; and forming a precipitate by reacting the compounds in an aqueous phase at an alkali pH.

Abstract: The invention relates to porous granular calcium phosphate osteoinductive materials, particularly materials useful in body tissue repair, principally bone repair and bone replacement, and also to the use of such materials and to a method of making such materials. Exemplary materials comprise discrete porous granules each containing crystals of at least one calcium phosphate, wherein (i) at least 90% of said crystals of the granules have a crystal size in the range 10-100 nm, (ii) at least 90% of the pores in the granules have a pore size in the range 10-500 nm, (iii) the average pore size of the pores having pore size in the range 10-500 nm in the granules is in the range 30-90 nm, (iv) the total volume porosity of the granules is at least 50%, and (v) the surface area of the granules is in the range 10-70 m2/g.

Abstract: Apparatus and systems may operate to enable positron emission imaging with a unitary chamber body having an open end that defines a hollow interior portion shaped to completely contain a flexible sleeve that is used to cover a core sample when the sleeve is seated within the hollow interior portion. An end cap may be formed to engage the open end of the chamber body, which is configured to attenuate gamma rays approximately eight times less than stainless steel, while supporting a pressure differential of at least 3 MPa between the chamber inlet and the outlet when fluid carrying a radioactive tag to generate the gamma rays flows through the hollow interior portion and the core sample via the inlet and the outlet. Additional apparatus, systems, and methods are disclosed.

Abstract: A process for the synthesis of a bioceramic composition comprising calcium phosphosilicate (CPS, Ca10(PO4)4(SiO4)2), the process comprising: providing calcium or a calcium-containing compound, a phosphorus-containing compound and a silicon-containing compound; and forming a precipitate by reacting the compounds in an aqueous phase at an alkali pH.

Abstract: A process for the synthesis of a bioceramic composition comprising calcium phosphosilicate (CPS, Ca10(PO4)4(SiO4)2), the process comprising: providing calcium or a calcium-containing compound, a phosphorus-containing compound and a silicon-containing compound; and forming a precipitate by reacting the compounds in an aqueous phase at an alkali pH.

Abstract: Apparatus and systems may operate to enable positron emission imaging with a unitary chamber body having an open end that defines a hollow interior portion shaped to completely contain a flexible sleeve that is used to cover a core sample when the sleeve is seated within the hollow interior portion. An end cap may be formed to engage the open end of the chamber body, which is configured to attenuate gamma rays approximately eight times less than stainless steel, while supporting a pressure differential of at least 3 MPa between the chamber inlet and the outlet when fluid carrying a radioactive tag to generate the gamma rays flows through the hollow interior portion and the core sample via the inlet and the outlet. Additional apparatus, systems, and methods are disclosed.

Abstract: An inorganic silicate-substituted calcium phosphate hydroxyapatite, useful as a biomaterial, has a Ca/P molar ratio in the range 2.05 to 2.55 and a Ca/(P+Si) molar ratio less than 1.66. The hydroxyapatite can be substantially free of carbonate ions. The material has relatively high solubility and is able to release silicon into solution.

Abstract: The bone graft system comprises a solid inorganic component, which is bone graft material, and a hydrogel. The hydrogel contains >2 ppm of silicon ions, calculated as parts by weight of Si per million of the aqueous component of the hydrogel. Preferably, the solid inorganic component comprises hydroxyapatite or a silicon-containing hydroxyapatite, and may be a silicon-containing hydroxyapatite having a Ca/P ratio in the range 2.05 to 2.55 and a Ca/(P+Si) molar ratio less than 1.66. Bone healing is promoted by delivery of silicon ion release from the hydrogel and by the solid inorganic component stimulating cell behavior.

Abstract: A synthetic calcium phosphate-based biomedical material comprising gadolinium. The material may comprise a compound having the general chemical formula: Ca10?yGdy(PO4)6?x(SiO4)x(OH)2?z+y where 0<x<1.3 and 0<y<1.3.